Press Releases
ATLANTA, April 12, 2023 – American Cancer Society (ACS) researchers are headed to Orlando, Florida this week for the annual meeting of the American Association of Cancer Research (AACR). The meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine.
ACS members will attend lectures, symposiums, and educational sessions at the meeting. They will also present important cancer research studies including these highlighted abstracts:
Dr. Hyuna Sung
- Survival of most commonly diagnosed second primary cancers among adult cancer survivors (Session date and time: 4/17, 1:30 p.m., ET)
- Survival among adults diagnosed with secondary acute myeloid leukemia (Session date and time: 4/18, 9:00 a.m., ET)
Dr. Hyunjung Lee
- Differential effects of social isolation on cancer mortality by race/ethnicity and socioeconomic status among working age adults in the United States (Session date and time: 4/17, 9:00 a.m., ET)
Dr. Ying Wang
-
Postdiagnosis adherence to American Cancer Society cancer prevention guidelines and mortality among survivors of obesity-related cancers (Session date and time: 4/19, 9:00 am, ET)
Other ACS researchers contributing to these studies at this year’s annual meeting include: Dr. Ahmedin Jemal, Rebecca Siegel, Dr. Farhad Islami, Christina Newton, Marjorie McCullough, Dr. Lauren Teras, Dr. Erika Rees-Punia, Dr. Caroline Um, and Dr. Alpa Patel.
# # #
About the American Cancer Society
The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 100 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit cancer.org or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, Twitter, and Instagram.